Related Experiment Video
Updated: May 25, 2026
07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
Sleep in older chronic pain patients: a comparative polysomnographic study
Tone Blågestad1, Ståle Pallesen, Linn-Heidi Lunde
1Department of Clinical Psychology, University of Bergen, Bergen, Norway. tone.blaagestad@gmail.com
The Clinical Journal of Pain
|February 15, 2012
Summary
Older adults with chronic pain experience poorer sleep quality, including longer sleep onset latency and reduced deep sleep intensity, compared to healthy individuals. This highlights the significant impact of chronic pain on restorative sleep architecture.
Area of Science:
- Gerontology
- Sleep Medicine
- Pain Management
Background:
- Chronic pain and sleep disturbances are frequently comorbid in older adults.
- The precise impact of chronic pain on objective sleep architecture remains incompletely understood.
- Polysomnography offers a comprehensive method for evaluating sleep macrostructure and microstructure.
Purpose of the Study:
- To compare polysomnography-derived sleep variables between older adults with chronic pain and healthy older controls.
- To investigate differences in sleep macrostructure and microstructure, including spectral analysis of specific frequency bands.
Main Methods:
- A naturalistic study utilizing polysomnography to assess sleep in older adults with chronic pain and age-matched healthy controls.
- Key sleep variables measured included sleep onset latency, sleep efficiency, wake time after sleep onset, and time spent in different sleep stages.
- Analysis also encompassed spectral power in alpha and delta frequency bands and indices for sleep-disordered breathing and periodic leg movements.
Main Results:
- The chronic pain group exhibited significantly longer time in bed, increased sleep onset latency, longer latency to N2 sleep, poorer sleep efficiency, and more awakenings.
- No significant differences were observed in total sleep duration or time spent in individual sleep stages between groups.
- Individuals with chronic pain showed reduced delta frequency band intensity, particularly in the first six hours of sleep, suggesting impaired deep sleep.
Conclusions:
- Older adults with chronic pain demonstrate objective sleep disturbances characterized by difficulties in sleep initiation and maintenance, alongside reduced deep sleep intensity.
- These findings underscore the detrimental effect of chronic pain on sleep quality and restorative processes in the elderly.
- Further research is warranted to explore therapeutic interventions targeting sleep disturbances in chronic pain populations.
More Related Videos
05:59High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Related Concept Videos
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...